ArticleJournal of the American Heart Association2025

Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation, and Down-Regulation of Mannose-6-Phosphate Receptors Cause Low Accessibility to Enzyme Replacement Therapy.

Andrea Frustaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.